Skip to content
2000
Volume 12, Issue 3
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Beta-blockers are considered as suitable drugs to treat essential hypertension also in elderly patients and they are currently recommended for treatment of hypertension, even in older patients, by the ESH/ESC Guidelines. Different meta-analyses and results of some large clinical trials have shown that here is no clinically difference between β-blockers and other drug classes in decreasing high blood pressure in elderly hypertensive patients. The new vasodilating β-blockers, as nebivolol, carvedilol and celiprolol, offer additional important advantages, compared with traditional β-blockers. The cardio-protective effect of β-blockers (except atenolol) is not inferior to that obtained with other drug classes which is independent of age and gender of the patients.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/1871525713666150310112759
2014-12-01
2025-10-29
Loading full text...

Full text loading...

/content/journals/chamc/10.2174/1871525713666150310112759
Loading

  • Article Type:
    Research Article
Keyword(s): Beta-blockers; elderly; hypertension
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test